Interventional pulmonology use of cell-free DNA assay for metastatic non–small cell lung cancer: the UC Davis experience
Background: Interventional pulmonologists (IPs) are often the first specialist to see patients with suspected metastatic non–small cell lung cancer (mNSCLC). Consequently, they are potentially ideally positioned to expedite the identification of actionable molecular mutations by ordering blood-based...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2022-11-01
|
| Series: | Therapeutic Advances in Respiratory Disease |
| Online Access: | https://doi.org/10.1177/17534666221135324 |